Johnson & Johnson (NYSE:JNJ)

164.40
Delayed Data
As of Jun 16
 -0.03 / -0.02%
Today’s Change
133.65
Today|||52-Week Range
173.65
+4.46%
Year-to-Date
Here's Why Orphazyme Shares Rocketed Higher on Wednesday
Jun 16 / MotleyFool.com - Paid Partner Content
Merck (MRK) Signs $1.2B Deal With US for COVID-19 Therapeutic
Jun 10 / Zacks.com - Paid Partner Content
Moderna Just Eliminated This 1 Risk
Jun 16 / MotleyFool.com - Paid Partner Content
Incyte's (INCY) sNDA Review for Jakafi in GVHD Gets Extended
Jun 09 / Zacks.com - Paid Partner Content
Novavax's (NVAX) COVID-19 Vaccine Shows 90% Efficacy in US Study
Jun 15 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: BIIB's Drug Approval, ALXN Drug Label Expansion & More
Jun 09 / Zacks.com - Paid Partner Content
Should Oshares U.S. Quality Dividend ETF (OUSA) Be on Your Investing Radar?
Jun 15 / Zacks.com - Paid Partner Content
Are You Looking for a High-Growth Dividend Stock? Johnson & Johnson (JNJ) Could Be a Great Choice
Jun 09 / Zacks.com - Paid Partner Content
3 Great Reasons to Buy Novavax
Jun 15 / MotleyFool.com - Paid Partner Content
Could Ocugen Be a Millionaire-Maker Stock?
Jun 09 / MotleyFool.com - Paid Partner Content
Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know
Jun 14 / Zacks.com - Paid Partner Content
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
Jun 08 / Zacks.com - Paid Partner Content
J&J (JNJ) Gets FDA Nod for 10M COVID Vaccines, Discards Many
Jun 14 / Zacks.com - Paid Partner Content
argenx (ARGX) to Regain AML Candidate After J&J's Dismissal
Jun 08 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) COVID-19 Jab's New Side Effect Stated by EMA
Jun 14 / Zacks.com - Paid Partner Content
Meme mania isn't going away anytime soon
Jun 08 / CNN.com - Paid Partner Content
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
Jun 14 / Zacks.com - Paid Partner Content
Where to Invest $1,000 Right Now
Jun 08 / MotleyFool.com - Paid Partner Content
Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?
Jun 14 / Zacks.com - Paid Partner Content
5 Top Dividend Kings to Buy and Hold Forever
Jun 08 / MotleyFool.com - Paid Partner Content
This Is Hands Down the Safest Robinhood Stock You Can Buy Right Now
Jun 14 / MotleyFool.com - Paid Partner Content
3 Stocks That Could Be Worth More Than Johnson & Johnson by 2035
Jun 06 / MotleyFool.com - Paid Partner Content
How Big Is Bristol Myers Squibb's Latest FDA Approval?
Jun 13 / MotleyFool.com - Paid Partner Content
How to Become a Millionaire With Your $175/Week Side Hustle
Jun 06 / MotleyFool.com - Paid Partner Content
Here's My Top Stock to Buy in June
Jun 13 / MotleyFool.com - Paid Partner Content
This Part of the Reopening Trade Is Just Getting Started
Jun 05 / MotleyFool.com - Paid Partner Content
Ocugen (OCGN) to File Coronavirus Vaccine BLA in US, Stock Tanks
Jun 11 / Zacks.com - Paid Partner Content
4 Reasons to Invest in Dividend-Paying Stocks for Retirement
Jun 04 / MotleyFool.com - Paid Partner Content
COVID-19 Jabs of Pfizer & Moderna May Lead to Inflamed Heart
Jun 11 / Zacks.com - Paid Partner Content
Why MorphoSys Stock Sank This Week
Jun 03 / MotleyFool.com - Paid Partner Content
Better Buy: Verizon Communications vs. Johnson & Johnson
Jun 11 / MotleyFool.com - Paid Partner Content
Covid vaccine profits mint 9 new pharma billionaires
May 21 / CNN.com - Paid Partner Content
Which Company Will Dominate the Teen Vaccination Market This Fall?
Jun 11 / MotleyFool.com - Paid Partner Content